NewsDesk @bactiman63 Research recently published in Clinical Infectious Diseases from the University of Minnesota Medical School has found that Fecal Microbiota Transplantation, or FMT, is an optimal...

The Food and Drug Administration (FDA) issued a safety alert this week informing health care providers and patients of the potential risk of transmission of SARS-CoV-2 virus by the use of fecal microbiota...

The U.S. Food and Drug Administration (FDA) issued a warning yesterday concerning the potential risks of Fecal Microbiota for Transplantation (FMT) following the death of a patient. Two immunocompromised...

New diagnostic methods and treatments – including fecal transplantation – will help improve the care of patients with Clostridium difficile (C. diff.), a deadly bacterial infection that can occur...

November is Clostridium difficile Awareness Month . The C. diff foundation says over 41 individuals lose their life to a Clostridium difficile infection (CDI) in the United States of America alone every...

Researchers from the Perelman School of Medicine at the University of Pennsylvania have found evidence that the most difficult C. difficile cases, known as multiple recurring C. difficile infections...

On the Sunday airing of the Outbreak News This Week Radio show, I was joined by two special guests discussing two important topics. In the first half, I look at the rare condition, usually brought on...

Clostridium difficile is the No. 1 hospital-acquired infection in the United States and leads to 29,000 deaths each year, according to the Centers for Disease Control and Prevention. The illness most...

Frozen and freeze-dried products for Fecal Microbiota Transplantation (FMT) are nearly as effective as fresh product at treating patients with Clostridium difficile (C-diff) infection, according to researchers...

In recent years, researchers have learned that gut microbiota play a role in a number of human diseases, including Clostridium difficile infection, irritable bowel syndrome, Parkinson’s disease, and...